Cubic Association of Glycated Hemoglobin A1c and Cardiocerebrovascular Mortality Risk in Middle‐Aged and Elderly Populations
International Journal of Clinical Practice · 2026-01 · 2026 (1)
DOI: 10.1155/ijcp/2379740 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Practice, online erschienen am 30.07.2026. Verfasst von Yinze Ji. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Despite evidence of a nonlinear association between glycated hemoglobin A1c (HbA1c) and the risk of cardiovascular events, the nonlinear relationship between HbA1c and cardiocerebrovascular mortality in middle‐aged and elderly adults has not been quantitatively characterized. Furthermore, it remains unclear whether this association is modified by diseases such as abdominal aortic calcification (AAC) and impaired kidney function. This study aimed to investigate the association between HbA1c and cardiocerebrovascular mortality among middle‐aged and elderly adults, quantify their nonlinear relationship, and explore whether this association could be modified by severe AAC or renal function impairment.
Methods
Middle‐aged and elderly participants from the National Health and Nutrition Examination Survey (NHANES) who underwent AAC assessment were included. Overall, 3135 NHANES participants were examined. With cardiocerebrovascular mortality as endpoint, Cox models with linear, restricted cubic spline (RCS), and polynomial terms of HbA1c were sequentially fitted to investigate the association between HbA1c and cardiocerebrovascular mortality and to investigate whether the relationship was linear or nonlinear. Subgroup analyses were conducted to test whether the association differed according to renal function and AAC severity. Hazard ratios (HRs) associated with a 1% increase in HbA1c were plotted to visualize the nonlinear association.
Results
After a median follow‐up period of 73 person‐months, 89 participants died from cardiocerebrovascular disease. The Cox model assuming a linear relationship between HbA1c and cardiocerebrovascular mortality failed to determine any relationship between the duo, whereas the RCS‐fitted Cox model identified an asymmetric, hill‐shaped nonlinear association between HbA1c and cardiocerebrovascular mortality. The parametric Cox model with polynomial terms confirmed this nonlinearity, specifically revealing a cubic association between the exposure and outcome. As HbA1c levels continued to rise, the HRs associated with each additional 1% increase in HbA1c rose from below 1.0, crossed the null value (HR = 1.0) at approximately 6.0%, peaked at approximately 8.0%, and subsequently decreased. No evidence of effect modification by severe AAC or severe renal function impairment was found.
Conclusions
A cubic, hill‐shaped association between HbA1c and cardiocerebrovascular mortality risk consistent between subgroups with different renal function and AAC severity was observed, underscoring the potential harm associated with overly stringent glycemic control in general middle‐aged and elderly populations. Findings of the study also indicate that cardiocerebrovascular disease may be an accomplice in mortality among participants with extremely poor glycemic control. An HbA1c level of 6.0% emerged as the minimum target of glycemic control for general middle‐aged and elderly populations.
Zitieren
APA
Ji, Y. (2026). Cubic Association of Glycated Hemoglobin A1c and Cardiocerebrovascular Mortality Risk in Middle‐Aged and Elderly Populations. International Journal of Clinical Practice, 2026(1). https://doi.org/10.1155/ijcp/2379740
Vancouver
Ji Y. Cubic Association of Glycated Hemoglobin A1c and Cardiocerebrovascular Mortality Risk in Middle‐Aged and Elderly Populations. International Journal of Clinical Practice. 2026;2026(1). doi:10.1155/ijcp/2379740
BibTeX
@article{Ji2026,
author = {Ji, Yinze},
title = {Cubic Association of Glycated Hemoglobin A1c and Cardiocerebrovascular Mortality Risk in Middle‐Aged and Elderly Populations},
journal = {International Journal of Clinical Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijcp/2379740}
}
EUVIMED